Assessment of bone marrow microvessel density in chronic lymphocytic leukemia

Applied Immunohistochemistry and Molecular Morphology

Volumn 18, Issue 4, 2010, Pages 353-356

  Antic, Darko ^a   Jovanovic, Maja Perunicic ^a   Fekete, Marija Dencic ^a   Cokic, Vladan ^a  

^a CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

bone marrow microvessel density; CLL

Indexed keywords

CD34 ANTIBODY; VON WILLEBRAND FACTOR;

ARTICLE; BLOOD VESSEL PARAMETERS; BONE MARROW; CANCER STAGING; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE COURSE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; MICROVASCULATURE; MICROVESSEL DENSITY; PRIORITY JOURNAL; VASCULARIZATION;

ANTIGENS, CD34; BONE MARROW; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MICROVESSELS; OBSERVER VARIATION; TUMOR MARKERS, BIOLOGICAL;

EID: 77954096959     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0b013e3181d18ae2     Document Type: Article

References (16)

1. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med. 1971;285:1182-1186.
2. Folkman J. Clinical applications of research on angiogenesis. N Engl J Med. 1995;333:1757-1763.
3. Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin Oncol. 2002;29:15-18.
4. Lim ST, Levine AM. Angiogenesis and hematological malignancies. Hematology. 2005;10:11-24.
5. Vacca A, Ribatti D, Roncali L, et al. Bone marrow angiogenesis and progression in multiple myeloma. Br J Haematol. 1994;87:503-508.
6. Vacca A, Ribatti D, Ruco L, et al. Angiogenesis extent and macrophage density increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas. Br J Cancer. 1999;79:965-970.
7. Rajkumar SV, Leong T, Roche PC, et al. Prognostic value of bone marrow angiogenesis in multiple myeloma. Clin Cancer Res. 2000;6: 3111-3116.
8. Kumar S, Fonseca R, Dispenzieri A, et al. Bone marrow angiogenesis in multiple myeloma: effect of therapy. Br J Haematol. 2002;119:665-671.
9. Shanafelt TD, Kay NE. The clinical and biologic importance of neovascularization and angiogenic signaling pathways in chronic lymphocytic leukemia. Semin Oncol. 2006;33:174-185. Review.
10. Norrby K, Ridell B. Tumour-type-specific capillary endothelial cell stainability in malignant B-cell lymphomas using antibodies against CD31, CD34 and Factor VIII. APMIS. 2003;111:483-489.
11. Smolej L, Kasparova P. Choice of endothelial marker is crucial for assessment of bone marrow microvessel density in chronic lymphocytic leukemia. APMIS. 2008;116:1058-1062.
12. Molica S, Vacca A, Ribatti D, et al. Prognostic value of enhanced bone marrow angiogenesis in early B-cell chronic lymphocytic leukemia. Blood. 2002;100:3344-3351.
13. Kini AR, Kay NE, Peterson LC. Increased bone marrow angiogen-esis in B cell chronic lymphocytic leukemia. Leukemia. 2000;14: 1414-1418.
14. Wolowiec D, Wozniak Z, Potoczek S, et al. Bone marrow angiogenesis and proliferation in B-cell chronic lymphocytic leukemia. Anal Quant Cytol Histol. 2004;26:263-270.
15. Negaard HF, Iversen N, Bowitz-Lothe IM, et al. Increased bone marrow microvascular density in haematological malignancies is associated with differential regulation of angiogenic factors. Leukemia. 2009;23:162-169.
16. Maffei R, Martinelli S, Castelli I, et al. Increased angiogenesis induced by chronic lymphocytic leukemia B cells is mediated by leukemia-derived Ang2 and VEGF. Leuk Res. 2009. [Epub ahead of print].